Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Silverman

Showing results (81-90 of 188) with videos related to

Pageof 19
Sort By:
Haematologica|May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemiaAmy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|July 28, 2016
How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology ClinicJustine M Kahn, Uma H Athale, Luis A Clavell, et al.
Pediatric Blood & Cancer|August 13, 2009
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaLynda M Vrooman, Jeffrey G Supko, Donna S Neuberg, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Blood|January 8, 2014
c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cellsJustine E Roderick, Jessica Tesell, Leonard D Shultz, et al.
Pageof 19

Showing results (81-90 of 188) with videos related to

Sort By:
Pageof 19
Haematologica|May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemiaAmy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|July 28, 2016
How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology ClinicJustine M Kahn, Uma H Athale, Luis A Clavell, et al.
Pediatric Blood & Cancer|August 13, 2009
Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemiaLynda M Vrooman, Jeffrey G Supko, Donna S Neuberg, et al.
Blood Advances|October 25, 2024
Recombinant Erwinia asparaginase (JZP458) in ALL/LBL: complete follow-up of the Children's Oncology Group AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Pharmacogenomics|August 2, 2014
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemiaFrancesco Ceppi, Chloé Langlois-Pelletier, Vincent Gagné, et al.
Clinical Pharmacology and Therapeutics|June 22, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic LeukemiaRachid Abaji, Vincent Gagné, Émilie Espagne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.
Blood Advances|July 11, 2023
Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trialsShai Shimony, Yael Flamand, Yannis K Valtis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2017
Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic LeukemiaYana Pikman, Gabriela Alexe, Giovanni Roti, et al.
Blood|January 8, 2014
c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cellsJustine E Roderick, Jessica Tesell, Leonard D Shultz, et al.
Pageof 19